{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:57:47Z","timestamp":1740135467312,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100007365","name":"Fondazione IRCCS Policlinico San Matteo (IT)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007365","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12872-016-0237-z","type":"journal-article","created":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T10:56:55Z","timestamp":1460631415000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Barnidipine compared to lercanidipine in addition to losartan on endothelial damage and oxidative stress parameters in patients with hypertension and type 2 diabetes mellitus"],"prefix":"10.1186","volume":"16","author":[{"given":"Giuseppe","family":"Derosa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amedeo","family":"Mugellini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa Maria","family":"Pesce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"D\u2019Angelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela","family":"Maffioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,12]]},"reference":[{"key":"237_CR1","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/00004872-200502000-00001","volume":"23","author":"H Brunner","year":"2005","unstructured":"Brunner H, Cockcroft JR, Deanfield J, Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension, et al. Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. J Hypertens. 2005;23:233\u201346.","journal-title":"J Hypertens"},{"key":"237_CR2","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.cardiores.2005.11.026","volume":"69","author":"JP Sluijter","year":"2006","unstructured":"Sluijter JP, de Kleijn DP, Pasterkamp G. Vascular remodeling and protease inhibition-bench to bedside. Cardiovasc Res. 2006;69:595\u2013603.","journal-title":"Cardiovasc Res."},{"key":"237_CR3","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.cardiores.2005.11.003","volume":"69","author":"CM Dollery","year":"2006","unstructured":"Dollery CM, Libby P. Atherosclerosis and proteinase activation. Cardiovasc Res. 2006;69:625\u201335.","journal-title":"Cardiovasc Res."},{"key":"237_CR4","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1161\/01.CIR.92.3.657","volume":"92","author":"E Falk","year":"1995","unstructured":"Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation. 1995;92:657\u201371.","journal-title":"Circulation"},{"key":"237_CR5","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0021-9150(03)00140-0","volume":"168","author":"AK Death","year":"2003","unstructured":"Death AK, Fisher EJ, McGrath KC, Yue DK. High glucose alters matrix metalloproteinase expression in two key vascular cells: potential impact on atherosclerosis in diabetes. Atherosclerosis. 2003;168:263\u20139.","journal-title":"Atherosclerosis"},{"issue":"3","key":"237_CR6","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/10623320600780942","volume":"13","author":"G Derosa","year":"2006","unstructured":"Derosa G, D'Angelo A, Ciccarelli L, et al. Matrix metalloproteinase-2, -9, and tissue inhibitor of metalloproteinase-1 in patients with hypertension. Endothelium. 2006;13(3):227\u201331.","journal-title":"Endothelium"},{"issue":"4","key":"237_CR7","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/10623320802228815","volume":"15","author":"G Derosa","year":"2008","unstructured":"Derosa G, Ferrari I, D'Angelo A, et al. Matrix metalloproteinase-2 and -9 levels in obese patients. Endothelium. 2008;15(4):219\u201324.","journal-title":"Endothelium"},{"issue":"4-5","key":"237_CR8","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/10623320701606475","volume":"14","author":"G Derosa","year":"2007","unstructured":"Derosa G, Cicero AF, Scalise F, et al. Metalloproteinases in diabetics and nondiabetics during acute coronary syndromes and after 3\u00a0months. Endothelium. 2007;14(4-5):175\u201383.","journal-title":"Endothelium"},{"issue":"2","key":"237_CR9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.diabet.2006.11.008","volume":"33","author":"G Derosa","year":"2007","unstructured":"Derosa G, D'Angelo A, Tinelli C, et al. Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in diabetic and healthy subjects. Diabetes Metab. 2007;33(2):129\u201334.","journal-title":"Diabetes Metab"},{"issue":"2","key":"237_CR10","doi-asserted-by":"crossref","first-page":"E124","DOI":"10.25011\/cim.v32i2.6030","volume":"32","author":"G Derosa","year":"2009","unstructured":"Derosa G, Maffioli P, D'Angelo A, et al. Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in combined dyslipidemia. Clin Invest Med. 2009;32(2):E124\u201332.","journal-title":"Clin Invest Med"},{"issue":"28","key":"237_CR11","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","volume":"34","author":"G Mancia","year":"2013","unstructured":"Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH\/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(28):2159\u2013219.","journal-title":"Eur Heart J"},{"issue":"21","key":"237_CR12","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.2169\/internalmedicine.47.1427","volume":"47","author":"R Fogari","year":"2008","unstructured":"Fogari R, Preti P, Zoppi A, et al. Effect of valsartan addition to amlodipine on insulin sensitivity in overweight-obese hypertensive patients. Intern Med. 2008;47(21):1851\u20137.","journal-title":"Intern Med"},{"issue":"8","key":"237_CR13","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1517\/14656566.2012.683175","volume":"13","author":"R Fogari","year":"2012","unstructured":"Fogari R, Zoppi A, Mugellini A, et al. Effects of valsartan or ramipril addition to amlodipine\/hydrochlorothiazide combination on left ventricular mass in diabetic hypertensive patients with left ventricular hypertrophy. Expert Opin Pharmacother. 2012;13(8):1091\u20139.","journal-title":"Expert Opin Pharmacother"},{"issue":"4","key":"237_CR14","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1527-3466.1997.tb00336.x","volume":"15","author":"T Sakai","year":"1997","unstructured":"Sakai T, Teramura T, Okamiya H, Inagaki O. A review on barnidipine: a novel calcium antagonist. Cardiovascular Drug Reviews. 1997;15(4):273\u201390.","journal-title":"Cardiovascular Drug Reviews"},{"issue":"3","key":"237_CR15","first-page":"173","volume":"1","author":"C Borghi","year":"2005","unstructured":"Borghi C. Lercanidipine in hypertension. Vasc Health Risk Manag. 2005;1(3):173\u201382.","journal-title":"Vasc. Health Risk Manag."},{"issue":"1","key":"237_CR16","first-page":"88","volume":"28","author":"L Ryd\u00e9n","year":"2007","unstructured":"Ryd\u00e9n L, Standl E, Bartnik M, Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC); European Association for the Study of Diabetes (EASD), et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J. 2007;28(1):88\u2013136.","journal-title":"Eur Heart J"},{"key":"237_CR17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1126\/science.635569","volume":"200","author":"HF Bunn","year":"1978","unstructured":"Bunn HF, Gabbay KH, Gallop PM. The glycosylation of haemoglobin. Relevance to diabetes mellitus. Science. 1978;200:21\u20137.","journal-title":"Science"},{"key":"237_CR18","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1046\/j.1464-5491.1999.00166.x","volume":"16","author":"European Diabetes Policy Group","year":"1999","unstructured":"European Diabetes Policy Group. A desktop guide to type 2 diabetes mellitus. Diabet Med. 1999;16:716\u201330.","journal-title":"Diabet Med"},{"issue":"12","key":"237_CR19","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1093\/clinchem\/45.12.2136","volume":"45","author":"N Rifai","year":"1999","unstructured":"Rifai N, Tracy RP, Ridker PM. Clinical Efficacy of an Automated High-Sensitivity C-Reactive Protein Assay. Clin Chem. 1999;45(12):2136\u201341.","journal-title":"Clin Chem"},{"key":"237_CR20","volume-title":"The Cytokine Handbook","author":"M Zhang","year":"1988","unstructured":"Zhang M, Tracey K. The Cytokine Handbook. 3rd ed. San Diego: Academic; 1988.","edition":"3"},{"issue":"1-2","key":"237_CR21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0009-8981(93)90024-X","volume":"221","author":"N Fujimoto","year":"1993","unstructured":"Fujimoto N, Mouri N, Iwata K, et al. A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 2 (72-kDa gelatinase\/type IV collagenase) using monoclonal antibodies. Clin Chim Acta. 1993;221(1-2):91\u2013103.","journal-title":"Clin Chim Acta"},{"issue":"1","key":"237_CR22","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0009-8981(94)90256-9","volume":"231","author":"N Fujimoto","year":"1994","unstructured":"Fujimoto N, Hosokawa N, Iwata K, et al. A one-step sandwich enzyme immunoassay for inactive precursor and complexed forms of human matrix metalloproteinase 9 (92\u00a0kDa gelatinase\/type IV collagenase, gelatinase B) using monoclonal antibodies. Clin Chim Acta. 1994;231(1):79\u201388.","journal-title":"Clin Chim Acta"},{"issue":"2","key":"237_CR23","first-page":"91","volume":"15","author":"AM Witkowska","year":"2004","unstructured":"Witkowska AM, Borawska MH. Soluble intercellular adhesion molecule-1 (sICAM-1): an overview. Eur Cytokine Netw. 2004;15(2):91\u20138.","journal-title":"Eur Cytokine Netw"},{"issue":"1","key":"237_CR24","first-page":"38","volume":"82","author":"K Peter","year":"1999","unstructured":"Peter K, Weirich U, Nordt TK, et al. Soluble vascular cell adhesion molecule-1 (VCAM-1) as potential marker of atherosclerosis. Thromb Haemost. 1999;82(1):38\u201343.","journal-title":"Thromb Haemost"},{"issue":"4","key":"237_CR25","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1177\/1074248406296108","volume":"11","author":"A Spirou","year":"2006","unstructured":"Spirou A, Rizos E, Liberopoulos EN, et al. Effect of barnidipine on blood pressure and serum metabolic parameters in patients with essential hypertension: a pilot study. J Cardiovasc Pharmacol Ther. 2006;11(4):256\u201361.","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"237_CR26","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1177\/089686080402400618","volume":"24","author":"EN Liberopoulos","year":"2004","unstructured":"Liberopoulos EN, Papavasiliou E, Miltiadous GA, et al. Alterations of paraoxonase and platelet-activating factor acetylhydrolase activities in patients on peritoneal dialysis. Perit Dial Int. 2004;24:580\u20139.","journal-title":"Perit Dial Int."},{"key":"237_CR27","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/01.hjh.0000163132.84890.c4","volume":"23","author":"E O'Brien","year":"2005","unstructured":"O'Brien E, Asmar R, Beilin L, European Society of Hypertension Working Group on Blood Pressure Monitoring, et al. Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens. 2005;23:697\u2013701.","journal-title":"J Hypertens"},{"key":"237_CR28","volume-title":"Statistical Principles in Experimental Design","author":"BJ Winer","year":"1971","unstructured":"Winer BJ. Statistical Principles in Experimental Design. 2nd ed. New York: McGraw-Hill; 1971.","edition":"2"},{"key":"237_CR29","doi-asserted-by":"crossref","first-page":"12603","DOI":"10.1038\/srep12603","volume":"5","author":"G Derosa","year":"2015","unstructured":"Derosa G, Mugellini A, Querci F, Franzetti I, Pesce RM, D'Angelo A, Maffioli P. Barnidipine or lercanidipine on echocardiographic parameters in hypertensive, type 2 diabetics with left ventricular hypertrophy: a randomized clinical trial. Sci Rep. 2015;5:12603.","journal-title":"Sci Rep."},{"key":"237_CR30","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2165\/00003495-200161070-00007","volume":"61","author":"HS Malhotra","year":"2001","unstructured":"Malhotra HS, Plosker GL. Barnidipine. Drugs. 2001;61:989\u201396.","journal-title":"Drugs"},{"key":"237_CR31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/080370598438546","volume":"1","author":"L Argenziano","year":"1998","unstructured":"Argenziano L, Izzo R, Iovino G, et al. Distinct vasodilation, without reflex neurohormonal activation, induced by barnidipine in hypertensive patients. Blood Press Suppl. 1998;1:9\u201314.","journal-title":"Blood Press Suppl."},{"key":"237_CR32","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejphar.2015.09.030","volume":"766","author":"G Derosa","year":"2015","unstructured":"Derosa G, Mugellini A, Pesce RM, D'Angelo A, Maffioli P. Perindopril and barnidipine alone or combined with simvastatin on hepatic steatosis and inflammatory parameters in hypertensive patients. Eur J Pharmacol. 2015;766:31\u20136.","journal-title":"Eur J Pharmacol."},{"issue":"10","key":"237_CR33","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/hr.2015.57","volume":"38","author":"G Derosa","year":"2015","unstructured":"Derosa G, Querci F, Franzetti I, Dario Ragonesi P, D'Angelo A, Maffioli P. Comparison of the effects of barnidipine\u2009+\u2009losartan compared with telmisartan\u2009+\u2009hydrochlorothiazide on several parameters of insulin sensitivity in patients with hypertension and type 2 diabetes mellitus. Hypertens Res. 2015;38(10):690\u20134.","journal-title":"Hypertens Res"},{"issue":"1","key":"237_CR34","first-page":"85","volume":"32","author":"R Farah","year":"2013","unstructured":"Farah R, Khamisy-Farah R, Shurtz-Swirski R. Calcium channel blocker effect on insulin resistance and inflammatory markers in essential hypertension patients. Int Angiol. 2013;32(1):85\u201393.","journal-title":"Int Angiol"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-016-0237-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T17:21:58Z","timestamp":1600449718000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-016-0237-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,12]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["237"],"URL":"https:\/\/doi.org\/10.1186\/s12872-016-0237-z","relation":{},"ISSN":["1471-2261"],"issn-type":[{"type":"electronic","value":"1471-2261"}],"subject":[],"published":{"date-parts":[[2016,4,12]]},"article-number":"66"}}